These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 17049227

  • 1. Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine.
    Temmink OH, Hoebe EK, Fukushima M, Peters GJ.
    Eur J Cancer; 2007 Jan; 43(1):175-83. PubMed ID: 17049227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Temmink OH, Hoogeland MF, Fukushima M, Peters GJ.
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590
    [Abstract] [Full Text] [Related]

  • 4. Differential activation of cell death and autophagy results in an increased cytotoxic potential for trifluorothymidine compared to 5-fluorouracil in colon cancer cells.
    Bijnsdorp IV, Peters GJ, Temmink OH, Fukushima M, Kruyt FA.
    Int J Cancer; 2010 May 15; 126(10):2457-68. PubMed ID: 19816940
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan].
    Xu JM, Li YM, Wang Y, Zhao CH, Yuan SJ, Yang WW, Li ZQ, Han Y, Azzariti A, Paradiso A.
    Zhonghua Zhong Liu Za Zhi; 2006 Aug 15; 28(8):578-82. PubMed ID: 17236550
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic interaction between trifluorothymidine and docetaxel is sequence dependent.
    Bijnsdorp IV, Kruyt FA, Gokoel S, Fukushima M, Peters GJ.
    Cancer Sci; 2008 Nov 15; 99(11):2302-8. PubMed ID: 18957056
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines.
    Sarcar B, Kahali S, Chinnaiyan P.
    J Neurooncol; 2010 Sep 15; 99(2):201-7. PubMed ID: 20135194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
    Zeghari-Squalli N, Raymond E, Cvitkovic E, Goldwasser F.
    Clin Cancer Res; 1999 May 15; 5(5):1189-96. PubMed ID: 10353756
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines.
    Bijnsdorp IV, Kruyt FA, Fukushima M, Smid K, Gokoel S, Peters GJ.
    Cancer Sci; 2010 Feb 15; 101(2):440-7. PubMed ID: 19886911
    [Abstract] [Full Text] [Related]

  • 15. Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
    Meco D, Di Francesco AM, Cusano G, Bucci F, Pierri F, Patriarca V, Torella AR, Pisano C, Riccardi R.
    Cancer Chemother Pharmacol; 2012 Dec 15; 70(6):811-22. PubMed ID: 23007316
    [Abstract] [Full Text] [Related]

  • 16. The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.
    LaBonte MJ, Manegold PC, Wilson PM, Fazzone W, Louie SG, Lenz HJ, Ladner RD.
    Int J Cancer; 2009 Dec 15; 125(12):2957-69. PubMed ID: 19536776
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
    Allegrini G, Goulette FA, Darnowski JW, Calabresi P.
    Cancer Chemother Pharmacol; 2004 Mar 15; 53(3):261-6. PubMed ID: 14658007
    [Abstract] [Full Text] [Related]

  • 20. Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines.
    Mans DR, Grivicich I, Peters GJ, Schwartsmann G.
    Eur J Cancer; 1999 Dec 15; 35(13):1851-61. PubMed ID: 10674003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.